US2857393A - Monoheterocyclic compounds - Google Patents

Monoheterocyclic compounds Download PDF

Info

Publication number
US2857393A
US2857393A US2857393DA US2857393A US 2857393 A US2857393 A US 2857393A US 2857393D A US2857393D A US 2857393DA US 2857393 A US2857393 A US 2857393A
Authority
US
United States
Prior art keywords
acid
thiazolidine
imino
formula
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Publication date
Application granted granted Critical
Publication of US2857393A publication Critical patent/US2857393A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Definitions

  • This invention relates to certain 2-imino-thiazolidine-4- ones of the formula:
  • R, and R stand for hydrocarbon radicals containing more than 2 carbon atoms, salts of such compounds, as well as the process for their preparation.
  • the hydrocarbon radicals R and R are more especial- 1y alkyl radicals containing from 3 to 14 carbon atoms, e. g. propyl, isopropyl, butyl, isobutyl, pentyl, or especially isopentyl, and furthermore S-methylpentyl, heptyl, octyl, nonyl, decyl, undecyl or dodecyl radicals; or alkenyl radicals, e. g. allyl or methallyl radicals.
  • Salts of the new compounds of this invention are particularly therapeutically useful acid addition salts such as those with inorganic acids, such as, hydrohalic acids, e. g. hydrochloric, hydrobromic or hydriodic acid; perchloric, nitric or thiocyanic acid; or sulfuric or phosphoric acids; or those with organic acids, such as, formic, acetic, propionic, glycolic, lactic, pyruvic, oxalic, malonic, succinic, maleic, fumaric, malic, tartaric, citric, ascorbic, hydroxymaleic, dihydroxymaleic, benzoic, phenylacetic, p-aminobenzoic, p-hydroxybenzoic, anthranilic, cinnamic, mandelic, salicylic, p-aminosalicylic, Z-phenoxybenzoic, 2-acetoxy-benzoic, methane sulfonic, ethane sulfonic, h
  • the new Z-imino-thiazolidine-4-ones and the salts thereof of this invention inhibit the growth of microorganisms such as bacteria or fungi and may be used as medicaments in the treatment of infections caused by microorganisms.
  • JI'QOR' in which R stands for hydrocarbon, e. g. alkyl or alkenyl radicals containing from 3 to 6 carbon atoms, and the therapeutically useful salts thereof, are particularly active against various type of Mycobacteria, such as Mycobizcterium tuberculosis or Mycobacterium leprae and can be used as antitubercular or antileprotic agents.
  • R stands for hydrocarbon, e. g. alkyl or alkenyl radicals containing from 3 to 6 carbon atoms, and the therapeutically useful salts thereof, are particularly active against various type of Mycobacteria, such as Mycobizcterium tuberculosis or Mycobacterium leprae and can be used as antitubercular or antileprotic agents.
  • An outstanding representative of this group of compounds is, for example, the Z-imino-thiazolidine-4-one of the formula:
  • OLIL I atent O "ice and the therapeutically useful acid addition salts, e. g. a hydrohalide thereof.
  • the new compounds may be used as medicaments in the form of pharmaceutical preparations, which contain the new compounds or salts thereof in admixture with .
  • a pharmaceutical organic or inorganic solid or liquid carrier suitable for enteral, parenteral or topical administration.
  • substances which do not react with the new compounds such as water, gelatine, lactose, starches, magnesium stearate, talc, vegetable oils, benzyl alcohols, gums, polyalkylene glycols, petroleum jelly, cholesterol or any other known carrier for medicaments.
  • the pharmaceutical preparations may be, for example, in the form of tablets, salves, dragees, creams, or in liquid form as solutions, suspensions or emulsions. If desired, they may contain auxiliary substances, such as preserving agents, stabilizing agents, wetting or emulsifying agents, salts for varying the osmotic pressure or buffers. They may also contain, in combination, other therapeutically useful substances.
  • the new 2-imino-thiazolidine-4-ones and their salts are prepared by reacting an N,N-d.i-substituted thiourea of the formula:
  • R and R stand for hydrocarbon radicals containing more than 2 carbon atoms, with an acetic acid or an ester thereof, substituted in a-position by a reactive esterified hydroxyl group and, if desired, converting any resulting salt into the free base, and/ or converting a free base obtained into a salt thereof.
  • a reactive esterifie'cl hydroxyl group is more especially a hydroxyl group esterified with a strong mineral acid, particularly a hydrohalic acid, e. g. hydrochloric, hydrobromic or hydriodic acid; or with a strong organic acid, e. g. p-toluene sulfonic acid.
  • An acetic acid ester is more especially an acetic acid lower alkyl ester, e. g. methyl, ethyl or propyl ester.
  • N,N'-disubstituted thioureas may be prepared by reacting substituted isothiocyanate with a substituted aniline; for example, the 4-isopentoxyphenyl-isothiocyanate may be reacted with 4-isopentoxyaaniline to form the N,N-di-(4- isopentoxyphenyl)-thiourea.
  • carbon disulfide may be reacted with-the .appropriately substitutedaniline derivative in the presence of a catalytic amount of an alkali metal salt of an alkyl xanthate, according to C. F. Huebner et al., I. Am. Chem..Soc., vol. 75, p. .2274 (1953), to yield a symmetrically N,N-bis-substituted thiourea.
  • the described reaction is carried out in the presence or absence of a solvent, at room 'or at an elevated temperature, in an open or closed. vessel under pressure, or in .the presence of an inertgas such as nitrogen; 'It is preferably conducted inasolvent, for example, an alcohol, suchras ethanol, if :desired,.in-the presence of an alkali metal salt of a lower alkanoic acid, e. g.
  • the-reaction may be completed more rapidlyiby refluxing the'mixture for 2 to 8 hours.
  • Any unreacted .thiourea 'whichcontaminates the final product may be identified by infrared studies or by the formation of an insoluble black precipitate upon addition of lead acetate to an alcoholic solution of the product. If necessary, the reaction may be1completed by reacting the product containing any unreacted thiourea with an additional amount of the u-halogeno-acid or an ester thereof.
  • the new compounds are obtained in the form'of the-free bases or salts thereof.
  • the salts may be converted into the free bases in the customary way, e. g. by reaction with an alkali metal hydroxide, such as sodium hydroxide.
  • the free bases may be'transformed into their therapeutically useful acid addition salts by reaction with appropriate inorganic or organic acids, e. g. the acidsoutlined above.
  • Example I A mixture of 13.8 g. of l,3-bis-(4'-propoxyphenyl)- thiourea, 5.8 g. of chloroacetic acid, and 11.0 g. of anhydrous fusedsodium acetate is suspended in 150 ml. of anhydrous ethanol and refluxed for 3%, .hours. The reaction mixture is filtered hot and allowed to crystallize under refrigeration. The material thus obtained is dissolved in benzene at room temperature, and the unreacted thiourea is filtered off. After removal of the solvent the filtrate yields the 2-(4'-propoxyphenylimino)- 3-(-4'-propoxyphenyl)-thiazolidine-4-one of the formula:
  • the hydrochloride may be prepared by adding to an ethanolic solution of 2-(4'-propoxyphenyl-imino)-3-(4'- propoxyphenyl)-thiazolidine-4-one a solution of hydrogen chloride in a mixture of ethanol and ether.
  • the oxalate may be prepared by adding oxalic acid to the ethanolic solution of 2-(4-propoxyphenyl-imino)-3-(4-propoxyphenyl)-thiazolidine-4-one.
  • Example 2 A mixture of 34 g. of 1,3-'bis (p -*allyloxyphenyl)- thiourea, 14.5 g. of chloroacetic acid and 25 g. of anhydrous sodium acetate is suspended in absolute ethanol and refluxed for 3 hours. The solution is filtered hot, the ethanol removed and the solid extracted with hot benzene. The solvent is removed from this extract and the residue is recrystallized twice from a mixture of benzene and methanol.
  • the 2-(4'-allyloxyphenyl-imino) 3 (4'- allyloxyphenyl)-thiazolidine-4-one of the formula:
  • Example 3 melts at l32-133.
  • Example 4 A mixture of 19 g. of 1,3-bis-[4'-(3-methylpentoxy)- phenyH-thiourea, 4.8 g. of chloroacetic acid and 12.5 g. of anhydrous sodium acetate in ml. isopropanol is refluxed for 4 /2 hours. The solution is filtered hot and the filtrate allowed to crystallize in the cold.
  • Example 5 A mixture of 30 g. of 1,3-bis-(4'-heptoxyphenyl)- thiourea, 6.2 g. of chloroacetic acid and 12 g. of anhydrous sodium acetate in 200 ml. isopropanol is refluxed for 6 hours. The solution is filtered hot and the crystals obtained by chilling the solution are recrystallized three times from isopropanol.
  • Example 6 A mixture of 13.5 g. of 1,3-bis-(p-butoxyphenyl)-thiourea, 5.3 g. of chloroacetic acid and 9.9 g. of anhydrous sodium acetate in 150 ml. of anhydrous alcohol is refluxed for 3% hours. The solution is filtered hot and the alcoholic filtrate concentrated to a small volume. The solid thus obtained is recrystallized once from a mixture of chloroform and petroleum ether and twice from cyclohexane, yielding the 2-(4-butoxyphenylimino)3 (4'-butoxyphenyl) thiazolidine-4 one of the formula:
  • Example 7 A mixture of 13.9 g. of 1,3-bis-(p-isobutoxyphenyl)- thiourea, 5.3 g. of chloroacetic acid and 10.1 g. of anhydrous sodium acetate in 175 ml. of anhydrous alcohol is refluxed for 6 hours. The solid which separates out upon chilling overnight is filtered oif and washed with alcohol. A second crop, obtained by concentration of the filtrate and washings, is combined with the first, and the material obtained is recrystallized once from a mixture of chloroform and petroleum ether, once from a mixture of benzene and petroleum ether and once from cyclohexane.
  • R and R stand for hydrocarbon radicals containing 3 to 14 carbon atoms selected from the group consisting of alkyl and alkenyl radicals, and salts thereof.
  • R stands for an alkyl radical containing 7 to 14 carbon atoms.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Description

United MON OHETEROCYCLIC COMPOUNDS porafion of New Jersey No Drawing. Application February 28, 1957 Serial No. 642,959
10 Claims. (Cl. 260-306.7)
This invention relates to certain 2-imino-thiazolidine-4- ones of the formula:
S NO-Om in which R, and R stand for hydrocarbon radicals containing more than 2 carbon atoms, salts of such compounds, as well as the process for their preparation.
The hydrocarbon radicals R and R are more especial- 1y alkyl radicals containing from 3 to 14 carbon atoms, e. g. propyl, isopropyl, butyl, isobutyl, pentyl, or especially isopentyl, and furthermore S-methylpentyl, heptyl, octyl, nonyl, decyl, undecyl or dodecyl radicals; or alkenyl radicals, e. g. allyl or methallyl radicals.
Salts of the new compounds of this invention are particularly therapeutically useful acid addition salts such as those with inorganic acids, such as, hydrohalic acids, e. g. hydrochloric, hydrobromic or hydriodic acid; perchloric, nitric or thiocyanic acid; or sulfuric or phosphoric acids; or those with organic acids, such as, formic, acetic, propionic, glycolic, lactic, pyruvic, oxalic, malonic, succinic, maleic, fumaric, malic, tartaric, citric, ascorbic, hydroxymaleic, dihydroxymaleic, benzoic, phenylacetic, p-aminobenzoic, p-hydroxybenzoic, anthranilic, cinnamic, mandelic, salicylic, p-aminosalicylic, Z-phenoxybenzoic, 2-acetoxy-benzoic, methane sulfonic, ethane sulfonic, hy-
droxyethane sulfonic, benzene sulfonic, p-toluene sulfonic, naphthalene sulfonic or sulfanilic acid or methionine, tryptophane, lysine or arginine.
The new Z-imino-thiazolidine-4-ones and the salts thereof of this invention inhibit the growth of microorganisms such as bacteria or fungi and may be used as medicaments in the treatment of infections caused by microorganisms. Thus, the 2-imino-thiazolidine-4-ones of the formula:
JI'QOR' in which R stands for hydrocarbon, e. g. alkyl or alkenyl radicals containing from 3 to 6 carbon atoms, and the therapeutically useful salts thereof, are particularly active against various type of Mycobacteria, such as Mycobizcterium tuberculosis or Mycobacterium leprae and can be used as antitubercular or antileprotic agents. An outstanding representative of this group of compounds is, for example, the Z-imino-thiazolidine-4-one of the formula:
SVN@0 cmomomona. OLIL I atent O "ice and the therapeutically useful acid addition salts, e. g. a hydrohalide thereof.
2-imino-thiazolidine-4-ones of the formula:
formula:
STNQO CH2 GCHI Q QHmw,
and the therapeutically useful acid addition salts, e. g. a hydrohalide thereof.
The new compounds may be used as medicaments in the form of pharmaceutical preparations, which contain the new compounds or salts thereof in admixture with .a pharmaceutical organic or inorganic solid or liquid carrier suitable for enteral, parenteral or topical administration. For making up the preparations there can be employed substances which do not react with the new compounds, such as water, gelatine, lactose, starches, magnesium stearate, talc, vegetable oils, benzyl alcohols, gums, polyalkylene glycols, petroleum jelly, cholesterol or any other known carrier for medicaments. The pharmaceutical preparations may be, for example, in the form of tablets, salves, dragees, creams, or in liquid form as solutions, suspensions or emulsions. If desired, they may contain auxiliary substances, such as preserving agents, stabilizing agents, wetting or emulsifying agents, salts for varying the osmotic pressure or buffers. They may also contain, in combination, other therapeutically useful substances.
The new 2-imino-thiazolidine-4-ones and their salts are prepared by reacting an N,N-d.i-substituted thiourea of the formula:
in which R and R stand for hydrocarbon radicals containing more than 2 carbon atoms, with an acetic acid or an ester thereof, substituted in a-position by a reactive esterified hydroxyl group and, if desired, converting any resulting salt into the free base, and/ or converting a free base obtained into a salt thereof.
A reactive esterifie'cl hydroxyl group is more especially a hydroxyl group esterified with a strong mineral acid, particularly a hydrohalic acid, e. g. hydrochloric, hydrobromic or hydriodic acid; or with a strong organic acid, e. g. p-toluene sulfonic acid. An acetic acid ester is more especially an acetic acid lower alkyl ester, e. g. methyl, ethyl or propyl ester.
-The startingmaterials used in this reaction-are known or may be prepared according to methods known for the preparation of analogous compounds. Thus, N,N'-disubstituted thioureas may be prepared by reacting substituted isothiocyanate with a substituted aniline; for example, the 4-isopentoxyphenyl-isothiocyanate may be reacted with 4-isopentoxyaaniline to form the N,N-di-(4- isopentoxyphenyl)-thiourea. Or, carbon disulfide may be reacted with-the .appropriately substitutedaniline derivative in the presence of a catalytic amount of an alkali metal salt of an alkyl xanthate, according to C. F. Huebner et al., I. Am. Chem..Soc., vol. 75, p. .2274 (1953), to yield a symmetrically N,N-bis-substituted thiourea.
The described reaction is carried out in the presence or absence of a solvent, at room 'or at an elevated temperature, in an open or closed. vessel under pressure, or in .the presence of an inertgas such as nitrogen; 'It is preferably conducted inasolvent, for example, an alcohol, suchras ethanol, if :desired,.in-the presence of an alkali metal salt of a lower alkanoic acid, e. g. sodium acetate; an :aromatic hydrocarbon, 'suchaas benzene; a halogenated' hydrocarbon, xsuch astchloroform; or a lower carboxylic'acid in the presence ,of an alkali metal salt of such an acid, for example, glacial acetic acid in the presence of sodium acetate. If desired, the-reaction may be completed more rapidlyiby refluxing the'mixture for 2 to 8 hours. Any unreacted .thiourea 'whichcontaminates the final product, may be identified by infrared studies or by the formation of an insoluble black precipitate upon addition of lead acetate to an alcoholic solution of the product. If necessary, the reaction may be1completed by reacting the product containing any unreacted thiourea with an additional amount of the u-halogeno-acid or an ester thereof.
Depending on the conditions used the new compounds are obtained in the form'of the-free bases or salts thereof. The salts may be converted into the free bases in the customary way, e. g. by reaction with an alkali metal hydroxide, such as sodium hydroxide. The free bases may be'transformed into their therapeutically useful acid addition salts by reaction with appropriate inorganic or organic acids, e. g. the acidsoutlined above.
The following examples are intended to illustrate the invention. They are not to be construed as being limitations thereon. Temperatures are given in degrees centigrade.
Example I A mixture of 13.8 g. of l,3-bis-(4'-propoxyphenyl)- thiourea, 5.8 g. of chloroacetic acid, and 11.0 g. of anhydrous fusedsodium acetate is suspended in 150 ml. of anhydrous ethanol and refluxed for 3%, .hours. The reaction mixture is filtered hot and allowed to crystallize under refrigeration. The material thus obtained is dissolved in benzene at room temperature, and the unreacted thiourea is filtered off. After removal of the solvent the filtrate yields the 2-(4'-propoxyphenylimino)- 3-(-4'-propoxyphenyl)-thiazolidine-4-one of the formula:
s Tar-Q CHaHv OLN Q-Ormnn which is twice recrystallized from a mixture of benzene and petroleum ether, M. P. 9698 C.
The hydrochloride may be prepared by adding to an ethanolic solution of 2-(4'-propoxyphenyl-imino)-3-(4'- propoxyphenyl)-thiazolidine-4-one a solution of hydrogen chloride in a mixture of ethanol and ether. The oxalate may be prepared by adding oxalic acid to the ethanolic solution of 2-(4-propoxyphenyl-imino)-3-(4-propoxyphenyl)-thiazolidine-4-one.
Example 2 A mixture of 34 g. of 1,3-'bis (p -*allyloxyphenyl)- thiourea, 14.5 g. of chloroacetic acid and 25 g. of anhydrous sodium acetate is suspended in absolute ethanol and refluxed for 3 hours. The solution is filtered hot, the ethanol removed and the solid extracted with hot benzene. The solvent is removed from this extract and the residue is recrystallized twice from a mixture of benzene and methanol. The 2-(4'-allyloxyphenyl-imino) 3 (4'- allyloxyphenyl)-thiazolidine-4-one of the formula:
SVNQO CHzOH=CHs is recrystallized twice from cold benzene, M. P. 76- 7 6.5 C.
Example 3 melts at l32-133.
Example 4 A mixture of 19 g. of 1,3-bis-[4'-(3-methylpentoxy)- phenyH-thiourea, 4.8 g. of chloroacetic acid and 12.5 g. of anhydrous sodium acetate in ml. isopropanol is refluxed for 4 /2 hours. The solution is filtered hot and the filtrate allowed to crystallize in the cold. The 2- [4'-(3-methylpentoxy)-phenyl-imino] 3 [4-(3-methylpentoxy)-phenyl]-thiazolidine-4-one of the formula:
I BVN0 omcmcnomom l l -0 Gunmen-0112011;
is dissolved in hot cyclohexane, filtered free of a small amount of insoluble matter and allowed to crystallize; M. P. 109-111".
Example 5 A mixture of 30 g. of 1,3-bis-(4'-heptoxyphenyl)- thiourea, 6.2 g. of chloroacetic acid and 12 g. of anhydrous sodium acetate in 200 ml. isopropanol is refluxed for 6 hours. The solution is filtered hot and the crystals obtained by chilling the solution are recrystallized three times from isopropanol. The 2-(4-heptoxyphenylimino) 3-(4'-heptoxyphenyl) thiazolidine-4-one of the formula:
melts at 97.5-98.5
Example 6 A mixture of 13.5 g. of 1,3-bis-(p-butoxyphenyl)-thiourea, 5.3 g. of chloroacetic acid and 9.9 g. of anhydrous sodium acetate in 150 ml. of anhydrous alcohol is refluxed for 3% hours. The solution is filtered hot and the alcoholic filtrate concentrated to a small volume. The solid thus obtained is recrystallized once from a mixture of chloroform and petroleum ether and twice from cyclohexane, yielding the 2-(4-butoxyphenylimino)3 (4'-butoxyphenyl) thiazolidine-4 one of the formula:
STN 0(CHs)aCH O=LN (C 2)aC s M. P. 103-106.
Example 7 A mixture of 13.9 g. of 1,3-bis-(p-isobutoxyphenyl)- thiourea, 5.3 g. of chloroacetic acid and 10.1 g. of anhydrous sodium acetate in 175 ml. of anhydrous alcohol is refluxed for 6 hours. The solid which separates out upon chilling overnight is filtered oif and washed with alcohol. A second crop, obtained by concentration of the filtrate and washings, is combined with the first, and the material obtained is recrystallized once from a mixture of chloroform and petroleum ether, once from a mixture of benzene and petroleum ether and once from cyclohexane. The 2-(4-isobutoxyphenyl-imino)-3-(4'- isobutoxyphenyl)-thiazolidine-4-one of the formula:
s No ornament), 0L1,
\QO cmcmom),
melts at 142-145".
What is claimed is:
1. A member of the group consisting of Z-imino-thiazolidine-4-ones of the formula:
in which R and R stand for hydrocarbon radicals containing 3 to 14 carbon atoms selected from the group consisting of alkyl and alkenyl radicals, and salts thereof.
2. 2-imino-thiazolidine-4-ones of the formula:
- isopentoxyisobutoxyin which R stands for an alkyl radical containing 7 to 14 carbon atoms.
10. 2-(4'-n heptoxyphenyl phenyl) -thiazolidine-4-one.
imino) -3-(4'-n heptoxy- References Cited in the file of this patent Bhargava: Chem. Abstracts, vol. 46, column 497 (1952).
Bhargava: Chem. Abstracts, vol. 46, column 11182 (1952).

Claims (1)

1. A MEMBER OF THE GROUP CONSISTING OF 2-IMINO-THIAZOLIDINE-4-ONES OF THE FORMULA:
US2857393D Monoheterocyclic compounds Expired - Lifetime US2857393A (en)

Publications (1)

Publication Number Publication Date
US2857393A true US2857393A (en) 1958-10-21

Family

ID=3447347

Family Applications (1)

Application Number Title Priority Date Filing Date
US2857393D Expired - Lifetime US2857393A (en) Monoheterocyclic compounds

Country Status (1)

Country Link
US (1) US2857393A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949460A (en) * 1959-01-26 1960-08-16 Ciba Pharm Prod Inc Certain thiazolidine-4-ones
US2949457A (en) * 1958-11-28 1960-08-16 Ciba Pharm Prod Inc Certain 2-phenyl-imino-3-phenyl-thiazolidine-4-ones

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949457A (en) * 1958-11-28 1960-08-16 Ciba Pharm Prod Inc Certain 2-phenyl-imino-3-phenyl-thiazolidine-4-ones
US2949460A (en) * 1959-01-26 1960-08-16 Ciba Pharm Prod Inc Certain thiazolidine-4-ones

Similar Documents

Publication Publication Date Title
US10183915B2 (en) Axially chiral isomers, and preparation methods therefor and pharmaceutical uses thereof
NO152972B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF 2- (1-PHENYL BENZIMIDAZOLYL) -ACETOH HYDROXIC ACID WITH THERAPEUTIC ACTIVITY
US2857393A (en) Monoheterocyclic compounds
US2929819A (en) New oxazoles
FR2631827A1 (en) NOVEL (HETERO) ARYL-5 TETRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC USE THEREOF
US3340301A (en) Bis-(para-tertiary aminoalkoxy-halogenophenyl)-cycloalkanes
US5240950A (en) Carbazate derivatives, their production and use
US2704757A (en) 5-hydroxy-3, 4, 5, 6-tetrahydropyriminines
AU2017333054B2 (en) Method for preparing phenylalanine compound
US3000885A (en) 2-acyl-10-oxyalkylpiperidinoalkylphenothiazines and process
US2969358A (en) 2-chloro-10-phenothiazinecarbonylpiperazines
US3321484A (en) Pyridinecarboxylic acid esters of cyclobutanediols
US3801581A (en) Alpha-phenyl-fatty acids substituted by azacycloalkyl residues and their derivatives
US2501858A (en) 4'(beta-ethyl)-morpholine ester of nicotinic acid and its production
US3030377A (en) Process for the manufacture of nitriles of tetracyclines
EP0017411B1 (en) Phthalazine cardiac stimulants, processes for preparing them, and pharmaceutical compositions containing them
US2477149A (en) Process for preparing penicillamines
US4174450A (en) Intermediates useful in the preparation of optically and therapeutically active-m-acyloxy-(methyl-amino) methyl benzyl alcohols
US3758527A (en) Esters of 1-aminoalkyl-cycloalkanols
US3350407A (en) Sulfur containing pyrazole derivatives
US3048594A (en) 1-ethyl-2-diphenylmethyl-piperidines
US2902491A (en) N-(piperidyl-2-ethyl)-n-(mercaptophenyl)-anilines
US2977362A (en) Piperazine derivatives
US2374367A (en) Process for preparing therapeutically active substances
US2923710A (en) Certain bis-1, 1-dipyridyl olefins and therapeutically useful salts